InvestorsHub Logo

stayfocused

11/17/14 12:42 PM

#10566 RE: RobinIV #10565

NRTI's worst qtrs are the 3rd and 4th qtrs, with the 4th qtr being the worst, (as is the rest of the vits industry historically) so there should be no surprises to anyone. The next 'apples to apples' comparison should be the 1st qtr 'Q' that comes out in mid may because not only is it the best qtr for NRTI but it should also be the first full qtr for the more recent distribution deals to be included. What will be interesting is the MSO and conv debt situations and how they impact the pps going forward whilst revs are under pressure. JMHO

Capt_Smith77

11/17/14 12:49 PM

#10567 RE: RobinIV #10565

If they were in fact giving away the product at much lower prices, then I think they'd make mention of it in their PRs, instead of comparing current revenues to sales #s from a year ago; numbers that are for the most part irrelevant when you consider that they've gone from having no products other than Surgex, to having four or more product lines.

Investors aren't stupid, and look more for quarter over quarter #s with all of the new products out, especially with MSE, which isn't cheap with their royalties. Being up front about needing or desiring to build these brands through cheaper, near give away prices would at least explain to investors that there's hope for the future. I'm not seeing this in their quarterly PRs, and they're also sitting on a lot more inventory then before, which is sad with all of their new stores lined up each quarter. The story with Inergetics and their current product lines is that they continuously add new stores that sell their products. I'd really like to know what each store is selling each month in $$$ terms, and what the ultimate decrease has been. It's my theory, too, that a lack of sales has forced some stores to neglect the products with future purchase orders.